Literature DB >> 3049674

Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.

S G Emerson1, Y C Yang, S C Clark, M W Long.   

Abstract

The hematopoietic stimulatory activities of human recombinant IL-3 and granulocyte-macrophage colony stimulating factor (GM-CSF) were directly compared using highly enriched human bone marrow progenitor target cells. IL-3 supported a larger number of erythroid and megakaryocytic progenitor cells than did GM-CSF, while GM-CSF supported more myeloid progenitors. IL-3 directly stimulated the division and migration of primitive erythroid burst forming units, while GM-CSF merely sustained their net survival in culture without promoting division and expansion. IL-3 promoted the formation of larger numbers of multipotential granulocyte-erythroid-macrophage-megakaryocyte colony forming unit--derived colonies than did GM-CSF. These data indicate that human IL-3 and GM-CSF have overlapping but distinct hematopoietic activities, and suggest a potential role for the clinical application of combined IL-3/GM-CSF therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049674      PMCID: PMC442680          DOI: 10.1172/JCI113727

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Interactions between purified GM-CSF, purified erythropoietin and spleen conditioned medium on hemopoietic colony formation in vitro.

Authors:  D Metcalf; G R Johnson
Journal:  J Cell Physiol       Date:  1979-05       Impact factor: 6.384

2.  Role of phorbol diesters in in vitro murine megakaryocyte colony formation.

Authors:  M W Long; J E Smolen; P Szczepanski; L A Boxer
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

3.  The growth of large megakaryocyte colonies from human bone marrow.

Authors:  H A Messner; N Jamal; C Izaguirre
Journal:  J Cell Physiol Suppl       Date:  1982

4.  A cell line secreting stimulating factors for CFU-GEMM culture.

Authors:  C D Myers; F E Katz; G Joshi; J L Millar
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

5.  Isolation of human haematopoietic progenitor cells using monoclonal antibodies.

Authors:  P C Beverley; D Linch; D Delia
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

6.  Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth.

Authors:  H Kimura; S A Burstein; D Thorning; J S Powell; L A Harker; P J Fialkow; J W Adamson
Journal:  J Cell Physiol       Date:  1984-01       Impact factor: 6.384

7.  Production of erythroid-potentiating activity by a human T-lymphoblast cell line.

Authors:  D W Golde; N Bersch; S G Quan; A J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Isolation and characterization of genomic and cDNA clones of human erythropoietin.

Authors:  K Jacobs; C Shoemaker; R Rudersdorf; S D Neill; R J Kaufman; A Mufson; J Seehra; S S Jones; R Hewick; E F Fritsch
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

Authors:  K Welte; E Platzer; L Lu; J L Gabrilove; E Levi; R Mertelsmann; M A Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

10.  Recombinant murine granulocyte macrophage colony-stimulating factor has megakaryocyte colony-stimulating activity and augments megakaryocyte colony stimulation by interleukin 3.

Authors:  B E Robinson; H E McGrath; P J Quesenberry
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

View more
  16 in total

1.  The influence of extra-cellular matrix and stroma remodeling on the productivity of long-term human bone marrow cultures.

Authors:  R M Schwartz; J Caldwell; M F Clarke; S G Emerson; B O Palsson
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures.

Authors:  R M Schwartz; B O Palsson; S G Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

3.  Effects of granulocyte/macrophage colony-stimulating factor on the development and differentiation of CD5-positive macrophages and their potential derivation from a CD5-positive B-cell lineage in mice.

Authors:  K Takahashi; K Miyakawa; A A Wynn; K Nakayama; Y Y Myint; M Naito; L D Shultz; A Tominaga; K Takatsu
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma. A phase-I study.

Authors:  J M Raemaekers; G W van Imhoff; L F Verdonck; J A Hessels; W E Fibbe
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

5.  A 29,000 molecular weight fraction from fetal rat liver adhering cells that cooperates with erythropoietin in stimulating the growth of erythroid progenitors.

Authors:  M D Nagel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-10       Impact factor: 2.416

6.  Regulation of interleukin 3 gene induction in normal human T cells.

Authors:  S C Guba; G Stella; L A Turka; C H June; C B Thompson; S G Emerson
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 7.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

8.  Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.

Authors:  F Herrmann; A Lindemann; W Lange; G Köchling; A Raghavachar; H Schrezenmeier; N Frickhofen; R H Mertelsmann
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

9.  Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro.

Authors:  Z Estrov; R Kurzrock; M Talpaz; M Blake; J U Gutterman
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

10.  Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.

Authors:  Saar Gill; Sarah K Tasian; Marco Ruella; Olga Shestova; Yong Li; David L Porter; Martin Carroll; Gwenn Danet-Desnoyers; John Scholler; Stephan A Grupp; Carl H June; Michael Kalos
Journal:  Blood       Date:  2014-03-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.